A role for the VLA-4 integrin in the activation of human memory B cells

被引:23
|
作者
Silvy, A
Altevogt, P
Mondiere, P
Bella, C
Defrance, T
机构
[1] INSERM U404,F-69365 LYON 07,FRANCE
[2] GERMAN CANC RES CTR,TUMOR IMMUNOL PROGRAM 0710,D-6900 HEIDELBERG,GERMANY
关键词
VLA-4; memory B cell; integrin;
D O I
10.1002/eji.1830271103
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
It is generally recognized that activation through membrane effector molecules such as CD40 or the B cell receptor (BCR) is mandatory to allow B cells to proliferate and differentiate into antibody (Ab)-secreting cells in response to cytokines. We show here that purified tonsillar B cells can be stimulated directly by a cytokine combination to proliferate and secrete immunoglobulins when cultures are performed at high cell density. The contact-mediated activation of B cells in this experimental system is strongly inhibited both by anti-very late antigen (VLA)-4 monoclonal Ab and by a peptide containing the LDV sequence specifically recognized by the alpha 4 integrin binding site. These reagents also significantly suppressed the B cell responses elicited by engagement of the BCR or CD40. Our data reveal that memory B cells but not virgin or germinal center B cells are sensitive to the direct stimulatory effect of cytokines in high-density cultures. Finally, we found that the dual expression of the alpha and beta chains of VLA-4 is a distinctive feature of the memory B cell population. Collectively, our findings support the notion that VLA-4-dependent homotypic B cell interactions can mediate a co-stimulatory signal to human memory B cells and might participate in the B cell activation triggered through the BCR and CD40.
引用
收藏
页码:2757 / 2764
页数:8
相关论文
共 50 条
  • [21] PLZF-mediated control on VLA-4 expression in normal and leukemic myeloid cells
    M T Quaranta
    I Spinello
    U Testa
    G Mariani
    D Diverio
    R Foà
    C Peschle
    C Labbaye
    Oncogene, 2006, 25 : 399 - 408
  • [22] The inhibition of the integrin VLA-4 in MV3 melanoma cell binding by non-anticoagulant heparin derivatives
    Schlesinger, Martin
    Schmitz, Patrick
    Zeisig, Reiner
    Naggi, Annamaria
    Torri, Giangiacomo
    Casu, Benito
    Bendas, Gerd
    THROMBOSIS RESEARCH, 2012, 129 (05) : 603 - 610
  • [23] Eosinophil VLA-4 binding to fibronectin augments bronchial narrowing through 5-lipoxygenase activation
    Munoz, NM
    Rabe, KF
    Neeley, SP
    Herrnreiter, A
    Zhu, XD
    McAllister, K
    Mayer, D
    Magnussen, H
    Galens, S
    Leff, AR
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 1996, 270 (04) : L587 - L594
  • [24] Co-engagement of α4β1 integrin (VLA-4) and CD4 or CD8 is necessary to induce maximal Erk1/2 phosphorylation and cytokine production in human T cells
    Kim, Tae Kon
    Billard, Matthew J.
    Wieder, Eric D.
    McIntyre, Bradley W.
    Komanduri, Krishna V.
    HUMAN IMMUNOLOGY, 2010, 71 (01) : 23 - 28
  • [25] Expression of VLA-4 on peripheral mononuclear cells in patients on chronic haemodialysis with carpal tunnel syndrome
    Ogino, M
    Namie, S
    Ozono, Y
    Miyazaki, M
    Harada, T
    Kohno, S
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (12) : 3126 - 3131
  • [26] Nitric oxide has a role in regulating VLA-4-integrin expression on the human neutrophil cell surface
    Conran, N
    Gambero, A
    Ferreira, HHA
    Antunes, E
    de Nucci, G
    BIOCHEMICAL PHARMACOLOGY, 2003, 66 (01) : 43 - 50
  • [27] Blockade of Integrin VLA-4 Prevents Inflammation and Matrix Metalloproteinase Expression in a Murine Model of Accelerated Collagen-Induced Arthritis
    Anil Raychaudhuri
    Mary Chou
    Marla Weetall
    Arco Y. Jeng
    Inflammation, 2003, 27 : 107 - 113
  • [28] Mobilization of myeloma cells involves SDF-1/CXCR4 signaling and downregulation of VLA-4
    Gazitt, Y
    Akay, C
    STEM CELLS, 2004, 22 (01) : 65 - 73
  • [29] Blockade of integrin VLA-4 prevents inflammation and matrix metalloproteinase expression in a murine model of accelerated collagen-induced arthritis
    Raychaudhuri, A
    Chou, M
    Weetall, M
    Jeng, AY
    INFLAMMATION, 2003, 27 (02) : 107 - 113
  • [30] BIO5192, a small molecule inhibitor of VLA-4, mobilizes hematopoietic stem and progenitor cells
    Ramirez, Pablo
    Rettig, Michael P.
    Uy, Geoffrey L.
    Deych, Elena
    Holt, Matthew S.
    Ritchey, Julie K.
    DiPersio, John F.
    BLOOD, 2009, 114 (07) : 1340 - 1343